Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
EUROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name NICOLETTO MARIA ORNELLA Address Istituto Oncologico Veneto Division of Medical Oncology 2 Via Gattamelata 64 35128 Padova Telephone Fax E-mail Nationality Date of birth + 39-049-8215260/8215913 + 39-049-8215904 [email protected] Italian June 23, 1953 WORK EXPERIENCE • Dates (from – to) • Name and adress of the employer • Occupation or position held • Dates (from – to) • Name and adress of the employer • Occupation or position held • Dates (from – to) • Name and adress of the employer • Occupation or position held • Dates (from – to) • Name and adress of the employer • Occupation or position held • Dates (from – to) • Name and adress of the employer • Occupation or position held 1986- present Division of Medical Oncology , Istituto Oncologico Veneto,IRCCS Padova Medical Ocology 1976-1979 Medical Division Padova Hospital Fellow 1980 - 85 Division of Medical Oncology, Padova Hospital, Fellow 1986-1991 Division of Medical Oncology, Padova Hospital Assistant Medical 1991-2004 Division of Medical Oncology Padova Hospital Assistant Director RESEARCH EXPERIENCE • Dates (from-to) • Name and type of organisation • Main Activities 1999-2000 Padova Hospital Study of new markers for predicting ovarian and breast cancer in collaboration with MD Anderson Cancer Center • Dates (from-to) • Name and type of organisation • Main Activities 1999-2004 Padova Hospital Prevention protocol for healty subjects from high risk families for breast and ovarian cancer • Dates (from-to) • Name and type of organisation • Main Activities 2002-2005 National Trial Treatment of metastatic breast cancer with Trastuzumab and other Anthracyclines • Dates (from-to) • Name and type of organisation • Main Activities 2004ICON trials about first and second line chemotherapy in ovarian cancer Partecipation • Dates (from-to) • Name and type of organisation 2003-2007 Industry and Institute Oncology Veneto Protecht Study (Prophylaxis of ThromboEmbolism during Chemotherapy) in solid tumors Partecipation • Main Activities • Dates (from - to) • Name and type of organisation • Main Activities 2010-2012 Industry and Istituto Oncologico Veneto Participation to clinical trial about new biological drug BIBF in ovarian cancer • Dates (from - to) • Name and type of organisation • Title of qualification awarded 2004-present Padova Istituto Oncologico Veneto Clinical Activity • Dates (from - to) • Name and type of organisation • Main Activities 1990-1997 Padova Hospital Design clinical trials in ovarian and breast cancer Clinical studies to improve treatment outcomes in metastatic ovarian cancer patients andin neoadjuvant Breast Cancer ACADEMIC POSITION • Dates (from - to) • Name and type of organisation • Principal subjects/occupational skills covered • Title of qualification awarded 1997-2009 School of Oncology as Residency Program University of Padova Clinical Oncology • Dates (from-to) • Name and type of organisation • Principal subjects/occupational skills covered • Title of qualification awarded 2003 – present Professor Gynecology and Obstetrics Residency Program, University of Padova Clinical Oncology Professor Professor EDUCATION AND TRAINING • Date 1983 • Name and type of organisation providing education and training • Principal subjects/occupational skills covered • Title of qualification awarded MOTHER TONGUE Padova University Oncology Specialty Italian OTHER LANGUAGES • Reading skills • Writing skills • Verbal skills ANNEXES English Good SUFFICIENT SUFFICIENT Research Grants Scientific Publications Scientific Affiliations Editorial Reviewer Board Research Grants Grants with Regional Agencies 1995-1996 “evaluation of Mitoxantrone in first line in Ovarian cancer “ – Research Program of the Veneto Government Commitee and Chairmanship Chairman, Gruppo Oncologico Nord-Est 1985-1998 Member, National MANGO society, M.Negri Milano, 2012-present Scientific Publications Has published 60 papers in Peer Reviewed Journals . The majority of papers regard the biological characterization and clinical trials in ovarian and breast cancer as of september 2013, Total Impact Factor= 336.422 Scientific Affiliations Italian Association Medical Oncology (AIOM) European Society Medical Oncology (ESMO) American Society Clinical Oncology (ASCO) International Gynecologic Cancer Society Editorial Board Cancer Chemotherapy Pharmacology Gynecology Oncology British Journal Cancer Oncology Tumori